5-Hydroxytryptamine2B receptors stimulate Ca2+ increases in cultured astrocytes from three different brain regions
Introduction
Serotonin [5-hydroxytryptamine (5-HT)] is an important neurotransmitter in the mammalian central nervous system (CNS), and disturbances in the 5-HT system have been demonstrated in several mental disorders, such as depression, anxiety, schizophrenia, and migraine. The 5-HT receptor family consists at present of seven major classes based on structural and pharmacological properties, the 5-HT1–7 receptors, which are further divided into several subtypes (Hoyer and Martin, 1997). Many of the receptors have been cloned and, with the exception of the 5-HT3 receptor, found to belong to the superfamily of G protein-coupled receptors with the predicted seven transmembrane-spanning structure (Saudou and Hen, 1994). The 5-HT2B receptor (previously named 5-HT2F) was originally cloned from the rat stomach fundus, where it is most abundant and causes smooth muscle contraction (Cohen and Fludzinski, 1987). 5-HT2B-receptor mRNA has been detected at low levels in the human brain (Kursar et al., 1994), and the 5-HT2B receptor has been shown in neurons from human cerebral cortex (Bonhaus et al., 1995). In rodent studies, stimulation of 5-HT2B receptors has been seen to induce anxiolysis, hyperphagia, and reduced grooming (Duxon et al., 1997a, Kennett et al., 1997, Kennett et al., 1996). However, some studies have failed to detect 5-HT2B mRNA in the rat CNS (Foguet et al., 1992, Kursar et al., 1992, Pompeiano et al., 1994), whereas others have found the receptor mRNA in the rat brain (Flanigan et al., 1995), in the spinal cord of rat (Helton et al., 1994), and the receptor protein in the cerebellum, septum, hypothalamus, and amygdala from rat (Duxon et al., 1997b). In cultured astrocytes the serotonin receptors were originally detected by Hertz and colleagues (Hertz et al., 1979), and to date six out of 14 currently known 5-HT receptor subtypes have been found in rat and mice. These are the 5-HT1A (Azmitia et al., 1996, Whitaker-Azmitia et al., 1993), the 5-HT2A (Deecher et al., 1993, Hagberg et al., 1998, Nilsson et al., 1991), the 5-HT5A (Carson et al., 1996), and the 5-HT6,7 receptors (Hirst et al., 1997). Recently, mRNA for the 5-HT2B receptor was shown in cultured rat astrocytes (Hirst et al., 1998). However, functional 5-HT2B receptors have hitherto not been reported on astrocytes.
The 5-HT2 receptors are thought to be linked to the release of intracellular Ca2+ induced by inositol 1,3,4-trisphosphate (IP3) (Kursar et al., 1992, Wainscott et al., 1993), and we have previously shown that 5-HT2A receptors on cultured astrocytes activate the phosphoinositol hydrolysis/Ca2+ signal transduction system (Nilsson et al., 1991) and open voltage-independent Ca2+ channels (Hagberg et al., 1998). The purpose of the present study was to investigate whether cultured astrocytes from different brain regions also express functional 5-HT2B receptors coupled to the intracellular Ca2+ homeostasis.
We here report 5-HT2B immunoreactivity on astrocytes in primary cultures from rat cerebral cortex, hippocampus, and brain stem. Microspectrofluorometric measurements of increases in [Ca2+]i after application of a selective 5-HT2B ligand indicate the expression of functional 5-HT2B receptors in these brain regions.
Section snippets
Astroglial cultures
Primary astroglial cultures were obtained from newborn Sprague–Dawley rats (Charles River, Uppsala, Sweden), as previously described (Hansson and Rönnbäck, 1989). Briefly, the animals were decapitated, the skull was opened, and the brain was removed. The meninges were stripped, and the cerebral cortex, hippocampus, and brain stem were dissected. The brain tissues were mechanically passed through an 80-μm-mesh nylon net into Eagle’s minimum essential medium (MEM, Life Technologies Ltd., Paisley,
Immunohistochemistry
Cells grown in primary astrocyte cultures from cerebral cortex, hippocampus and, brain stem for 9–20 days were immunohistochemically positive for the astroglial marker glial fibrillary acid protein (GFAP). A subpopulation of approximately 50% of the GFAP+ cells also stained positive with antibodies against the 5-HT2B receptor, showing a cytoplasmic punctate pattern, similar to previous studies using labelled serotonin (Whitaker-Azmitia, 1988) (Fig. 1A and B). Immunolabelling was also seen along
Discussion
The present study provides immunohistochemical and functional evidence for the expression of 5-HT2B receptors on astrocytes in primary culture from three different brain regions. By using antibodies against the 5-HT2B receptor, it was possible to recognize the receptor on GFAP-positive cells from rat cerebral cortex, hippocampus, and brain stem. The presence of the 5-HT2B receptor on the astrocytes was also confirmed with Western blot analyses. When the astrocytes were stimulated with the 5-HT2B
Acknowledgements
The technical skills of Ulrika Johansson and Barbro Eriksson are greatly appreciated. We thank Peter S. Eriksson, Institute of Clinical Neuroscience, Göteborg University, Sweden, for kindly providing access to laboratory space and equipment. This project was funded by grants from the Swedish Medical Research Council (Project No. 33X-06812), Edit Jacobsson’s Foundation, the Medical Faculty of Göteborg and the Swedish Society for Medical Research.
References (58)
- et al.
Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells
Neuropsychopharmacol.
(1996) - et al.
5-HT2 receptor subtypes: a family re-united?
Trends. Pharmacol. Sci.
(1995) - et al.
5-hydroxytryptamine and glutamate modulate velocity and extent of intercellular calcium signalling in hippocampal astroglial cells in primary cultures
Neurosci.
(1999) - et al.
Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system
Neuroscience
(1997) - et al.
Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat
Neuropharmacol.
(1997) - et al.
In situ molecular sizes of the various types of 5-HT binding sites in the brain
Biochem. Pharmacol.
(1986) - et al.
Stimulation of 5-HT2A receptors on astrocytes in primary culture opens voltage-independent Ca2+ channels
Neurochem. Int.
(1998) - et al.
Cultured astrocytes express messenger RNA for multiple serotonin receptor subtypes, without functional coupling of 5-HT1 receptor subtypes to adenyl cyclase
Mol. Brain Res.
(1998) - et al.
5-HT receptor classification and nomenclature: towards a harmonization with the human genome
Neuropharmacology
(1997) - et al.
BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats
Neuropharmacology
(1997)
Neurotransmitters as growth regulatory signals: role of receptors and second messengers
Trends Neurosci.
In vivo and in vitro development of serotonergic neurons
Brain. Res. Bull.
Ras involvement in signal transduction by the serotonin 5-HT2B receptor
J. Biol. Chem.
Protein measurement with folin phenol reagent
J. Biol. Chem.
Astrocytes play a role in regulation of synaptic density
Brain Res.
GABA induces Ca2+ transients in astrocytes
Neuroscience
Adrenergic and 5-HT2 receptors on the same astroglial cell. A microspectrofluorimetric study on cytosolic Ca2+ responses in single cells in primary culture
Brain. Res. Dev. Brain. Res.
Neuronal/glial plasisity in the supraoptic dendritic zone: dendritic bundling and double synapse formation at parturition
Neurosci.
A simplification of the protein assay method of Lowry et al. which is more generally applicable
Anal. Biochem.
Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors
Brain Res. Mol. Brain Res.
Neuronal-glial interactions during brain development
Trends Neurosci.
5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates
Neurochem. Int.
Delta-opioid receptors on astroglial cells in primary culture: mobilization of intracellular free calcium via a pertussis sensitive G-protein
Neuropharmacol.
Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle
Br. J. Pharmacol.
The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors
Br. J. Pharmacol.
The 5-HT5A serotonin receptor is expressed predominantly by astrocytes in which it inhibits cAMP accumulation: a mechanism for neuronal suppression of reactive astrocytes
GLIA.
The mouse 5-HT2B receptor: possible involvement in trophic functions of serotonin
Cell. Mol. Biol.
Mouse 5-HT2B receptor-mediated serotonin trophic functions
Ann. N. Y. Acad. Sci.
Cited by (48)
Serotonin modulation of hippocampal functions: From anatomy to neurotherapeutics
2021, Progress in Brain ResearchCitation Excerpt :The expression of 5-HT2B receptors in the hippocampus was showed in astroglial cells immunohistochemically and by Western blot analysis in rats (Sanden et al., 2000) and by qPCR in humans (Bevilacqua et al., 2010). The astrocytic 5-HT2B receptors seem to be functional and indeed their pharmacological stimulation induced increases in intracellular Ca2 + that were independent of extracellular Ca2 + and are considered to be the result of release from intracellular stores, mediated most plausibly via phospholipase C (PLC)-activated formation of IP3, although other sources of intracellular Ca2 + cannot be excluded (Sanden et al., 2000). KO mice for the gene encoding the 5-HT2B receptor display an “antidepressant-like phenotype,” which includes reduced latency to feed in the novelty suppressed feeding test, basal increase in hippocampal brain-derived neurotrophic factor (BDNF) levels, no change in TrkB and p75 protein levels, and an increased preference for sucrose consumption (Diaz et al., 2016).
The serotonin<inf>2B</inf> receptor and neurochemical regulation in the brain
2020, Handbook of Behavioral NeuroscienceCitation Excerpt :In rats, the presence of 5-HT2BRs has been demonstrated in primary astrocyte cultures of the cerebral cortex, hippocampus, colliculus, cerebellum, and brainstem (Hirst, Cheung, Rattray, Price, & Wilkin, 1998; Sandén, Thorlin, Blomstrand, Persson, & Hansson, 2000), although a previous study has failed to detect the 5-HT2BR in rat brain astrocytes (Duxon et al., 1997). Of note, in the rodent, all the available studies, except those by Duxon et al. (1997), Launay et al. (2006), and Sandén et al. (2000), investigated the presence of the 5-HT2BR mRNA, which is not necessarily predictive of the presence of the protein. Additional investigations are warranted to precisely determine the brain expression of the 5-HT2BR.
Serotonin neurobiology in cocaine use disorder
2020, Handbook of Behavioral NeuroscienceCitation Excerpt :Prominently localized in peripheral tissues (e.g., heart, kidney, liver), the 5-HT2BR was identified to mediate the heart valve pathogenesis caused by the antiobesity compound fenfluramine which was withdrawn from the market due to its toxicity consequent to chronic use (for reviews, Rothman, & Baumann, 2009; Elangbam, 2010). While studies of brain localization of 5-HT2BR protein are limited (Duxon et al., 1997; Launay, Schneider, Loric, Da Prada, & Kellermann, 2006; Sanden, Thorlin, Blomstrand, Persson, & Hansson, 2000), 5-HT2BR mRNA is expressed at low levels in several brain regions (e.g., DRN, cortex, amygdala, hypothalamus) (Bevilacqua et al., 2010; Bonhaus et al., 1995), including raphe 5-HT neurons, astrocytes and microglia (Kolodziejczak et al., 2015; Launay et al., 2006). Maroteaux also described 5-HT2BR mRNA expression in a subpopulation of VTA DA neurons projecting specifically to the NAc shell in rats (Doly et al., 2017).
Serotonin increases ERK<inf>1/2</inf> phosphorylation in astrocytes by stimulation of 5-HT<inf>2B</inf> and 5-HT<inf>2C</inf> receptors
2010, Neurochemistry International